Adverse effects and interactions in therapy with psychopharmaceuticals
Payk, T.R.
Medizinische Monatsschrift für Pharmazeuten 2(11): 336-340
1979
ISSN/ISBN: 0342-9601 PMID: 554930 Document Number: 153460
Document emailed within 1 workday
Related Documents
Kaye, S.; Ortiz, T.; Miranda Massari, J.R.; González, M.J. 2003: Adverse effects and interactions of medicinal herbal products Boletin de la Asociacion Medica de Puerto Rico 95(6): 32-36; 40-41Wynn, R.L. 1994: Dental drug interactions with the greatest potential for serious adverse effects General Dentistry 42(2): 116-117
Gerstoft, J. 2000: HIV-treatment. Interactions, compliance, prolonged adverse effects and global accessibility Ugeskrift for Laeger 162(35): 4639
Robinson, D.S. 1984: Adverse reactions, toxicities, and drug interactions of newer antidepressants: anticholinergic, sedative, and other side effects Psychopharmacology Bulletin 20(2): 280-290
Breithaupt, H.; Fellmann, A. 1978: Therapy using psychopharmaceuticals (I) Die Medizinische Welt 29(34): 1301-1305 Contd
Friis, B.; Thomsen, J. 1979: Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin Ugeskrift for Laeger 141(29): 1968-1972
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Gerdén, B. 2005: The Medical Products Agency about SSRi to pregnant women and adverse effects on the fetus. Long-term adverse effects are not proved, documentation is insufficient, more research is necessary Lakartidningen 102(10): 791
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Schmidmeier, R. 2006: Somatic side effects of psychopharmaceuticals MMW Fortschritte der Medizin 148(46): 27-29
Ramachandran, S. 1973: Adverse effects of emetine therapy Ceylon Medical Journal 18(3): 138-143
Cleator, I.G. 1983: Adverse effects of ranitidine therapy Canadian Medical Association Journal 129(5): 405
Halparin, L.S. 1984: Adverse effects of ranitidine therapy Canadian Medical Association Journal 130(6): 668; 672
Gossius, G. 1986: Adverse effects in trimethoprim therapy Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(2): 147-149
Wig, N. 2002: Antiretroviral therapy: are we aware of adverse effects? Journal of the Association of Physicians of India 50: 1163-1171
Schöpf, E. 1972: Adverse effects of external corticosteroid therapy Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 23(7): 295-301
Krecke, H.J. 1971: Adverse effects and complications of diuretic therapy Der Internist 12(5 Suppl): 357-364
Brunner, H.; Horak, W.; Grabner, G. 1976: Adverse effects of chenodeoxycholic-acid therapy Zeitschrift für Gastroenterologie. Verhandlungsband 9: 55-59
Olejárová, M. 2017: Adverse effects of biological therapy in rheumatology Vnitrni Lekarstvi 62(7-8): 605-612